Article
Construction and validation of a colon cancer prognostic model based on tumor mutation burden-related genes.
Scientific reports - 4 Feb 2024
Zou Daoyang, Xu Tianwen
Abstract excerpt
Currently, immunotherapy has entered the clinical diagnosis and treatment guidelines for colon cancer, but existing immunotherapy markers cannot predict the effectiveness of immunotherapy well. This study utilized the TCGA-COAD queue to perform differential gene analysis on high and low-mutation burden samples, and screen differentially expressed genes (DEGs). To explore new molecular markers or predictive models...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
